The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying ...

Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop ...

Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo ...

COMPANY ANNOUNCEMENT No. 230/2025 Tvis, 6 August 2025 TCM Group A/S revise full year guidance for 2025 As the closing of the ...

Revenue at the unit, which houses AMD’s all-important artificial intelligence chips that are viewed as central to the company ...

NVO's Q2 earnings beat but revenues miss estimates as Wegovy and Ozempic face U.S. setbacks and rising competition.

Orion Oyj Series A posted the largest decline among large stocks during the session, declining 7.8%, followed by Embla Medical hf. shares, which declined 7.7%. Shares of Orion Oyj Series B declined ...

Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of ...

A: The news says comic superstar Snoopy’s birthday is coming soon on Aug. 10. B: So he’s a Leo, and his birthday will fall on ...

Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

MFPEN, Nicklas Skovgaard, and STEL are the finalists for the 2025 Wessel & Vett Fashion Prize. The winner receives 67,000 ...